查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球頭頸癌治療市場規模、份額和行業趨勢分析報告：按治療類型、給藥途徑、分銷渠道和地區劃分的展望和預測，2022-2028 年
市場調查報告書
商品編碼
1172683

全球頭頸癌治療市場規模、份額和行業趨勢分析報告：按治療類型、給藥途徑、分銷渠道和地區劃分的展望和預測，2022-2028 年

Global Head And Neck Cancer Therapeutics Market Size, Share & Industry Trends Analysis Report By Therapy Type, By Route of Administration, By Distribution Channel, By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 206 Pages | 訂單完成後即時交付

價格

到 2028 年，全球頭頸癌治療市場規模預計將達到 25 億美元，預測期內復合年增長率為 12.3%。

手術干預、放療、化療、靶向治療和免疫治療是主要的癌症治療方法。 治療計劃可能包括單獨的手術或放射治療，或兩者的結合。 特定頭頸癌的行為取決於它的起源位置（原發部位）。

例如，長在聲帶上的腫瘤和長在距聲帶僅約 1 厘米的舌後部的腫瘤表現完全不同。 鱗狀細胞癌起源於鼻子、嘴巴和喉嚨的細胞，是頭頸部最常見的癌症。

COVID-19 影響分析

COVID-19疫情對不同類型頭頸癌患者的治療產生了重大影響，其中老年患者影響較大，主要是接受手術的患者，並發症較少的患者增加。 由於漏診或延誤診斷，這些患者的腫瘤學結果可能更差。 COVID-19 疫情推遲或重新安排了一些癌症檢測，導致大量人得不到必要的醫療救助。 這種對癌症篩查計劃的破壞可能會對患者、醫護人員和醫療保健系統產生重大影響。

市場增長因素

對免疫療法的需求不斷增長

免疫療法是一種針對頭頸癌、淋巴瘤、黑色素瘤和非小細胞肺癌等癌症的創新療法。 一些腫瘤對化學療法等常規治療反應良好。 免疫療法也可以與傳統的癌症治療一起使用，以增強身體對癌症的天然防禦能力。 作為其正常功能的一部分，免疫系統通過發現和消除異常細胞來預防或抑制某些惡性腫瘤的形成。 例如，可以在腫瘤內部和周圍發現免疫細胞。

患者數量增加推動市場增長

頭頸癌根據其位置分類。 這些部位包括口腔、咽、喉、鼻竇、鼻腔和唾液腺。 酒精和煙草消費的增加是頭頸癌的主要原因。 據估計，75% 的頭頸癌是由飲酒和吸煙引起的。 癌症是導致死亡的主要原因，導致超過 1000 萬人死亡，即每 6 人中就有 1 人死亡。

市場製約因素

化療的副作用

頭頸癌通常採用放療和化療相結合的方法進行治療。 它的副作用包括脫髮、言語障礙和失聲。 此外，在接受癌症手術後，進食變得困難。 脫髮是化療的常見副作用，但並不是每個人都會發生。 個人可以詢問他們的醫生這是否可能是藥物的副作用。

治療類型

根據治療類型，頭頸癌治療市場分為化學療法、免疫療法和靶向療法。 到 2021 年，免疫治療領域將在頭頸治療市場佔據最高的收入份額。 那是因為免疫療法使用免疫系統來治療癌症。 Pembrolizumab 是一種針對缺乏 DNA 修復能力的細胞的抗 PD1 免疫療法，可能屬於這一類。

管理路線展望

頭頸癌藥物市場根據給藥途徑分為註射劑和口服藥物。 到 2021 年，口服部分在頭頸癌藥物市場中佔據了很大的收入份額。 這是由於越來越多的口服藥物用於治療頭頸癌患者。 試驗的成功完成和隨後的推出預計將刺激細分市場的增長。 此外，正在對癌症患者進行口服化療。

分銷渠道前景

按分銷渠道，頭頸癌藥物市場分為零售藥店和專業藥店、住院藥店和在線藥店。 2021 年，零售和專業藥店將在頭頸癌藥物市場中佔據最高的細分市場份額。 這是因為專業藥店提供傳統藥店所沒有的藥物，例如免疫治療藥物。 通過專業藥房提供這些藥物可確保它們的正確和安全交付。

區域展望

按地區分析，分析了北美、歐洲、亞太地區和 LAMEA 的頭頸癌治療市場。 2021 年，北美市場在頭頸癌治療市場的收入份額最大。 這歸因於政府對醫療保健行業擴張的支持、有吸引力的報銷規定、對該疾病的高度認識以及易於獲得優質醫療設施等因素，以及有助於該地區市場擴張的其他因素。

內容

第一章市場範圍與研究方法

  • 市場定義
  • 目的
  • 市場規模
  • 細分
    • 全球頭頸癌藥物市場，按治療類型
    • 按給藥途徑劃分的頭頸癌藥物全球市場
    • 全球頭頸癌藥物市場（按分銷渠道）
    • 全球頭頸癌藥物市場，按地區
  • 調查方法

第 2 章市場概述

  • 簡介
    • 簡介
      • 市場構成和情景
  • 影響市場的主要因素
    • 市場驅動因素
    • 市場製約因素

第 3 章部署在頭頸癌藥物市場的戰略

第 4 章全球頭頸癌藥物市場：按治療類型分類

  • 全球免疫療法市場：按地區
  • 全球化療市場：按地區
  • 全球靶向治療市場：按地區

第 5 章全球頭頸癌藥物市場：按給藥途徑分類

  • 全球注射劑市場，按地區劃分
  • 全球口服藥市場：按地區

第 6 章。全球頭頸癌藥物市場：按分銷渠道

  • 全球零售和專業藥房市場，按地區
  • 按地區劃分的全球住院藥房市場
  • 全球在線藥店區域市場

第 7 章：全球頭頸癌藥物市場：按地區分類

  • 北美
    • 按國家/地區劃分的北美頭頸癌藥物市場
      • 美國
      • 加拿大
      • 墨西哥
      • 其他北美地區
  • 歐洲
    • 按國家/地區劃分的歐洲頭頸癌藥物市場
      • 德國
      • 英國
      • 法國
      • 俄羅斯
      • 西班牙
      • 意大利
      • 其他歐洲
  • 亞太地區
    • 亞太地區頭頸癌藥物市場：按國家/地區分類
      • 中國
      • 日本
      • 印度
      • 韓國
      • 新加坡
      • 馬來西亞
      • 其他亞太地區
  • 拉美
    • LAMEA 頭頸癌藥物市場：按國家/地區分類
      • 巴西
      • 阿根廷
      • 阿聯酋
      • 沙特阿拉伯
      • 南非
      • 尼日利亞
      • LAMEA 的其餘部分

第八章公司簡介

  • Eli Lilly And Company
  • Merck & Co., Inc.
  • Sanofi S.A
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • F. Hoffmann-La Roche Ltd.
  • AstraZeneca PLC
  • Bristol Myers Squibb Company
  • Clinigen Group PLC

The Global Head And Neck Cancer Therapeutics Market size is expected to reach $2.5 billion by 2028, rising at a market growth of 12.3% CAGR during the forecast period.

The majority of malignancies that are jointly referred to as head and neck cancers begin in the squamous cells that cover the mucosal surfaces of the head and neck. These tumors are known as head and neck squamous cell carcinomas. Head and neck malignancies can also begin in the salivary glands, muscles, sinuses, or nerves in the head and neck, however, squamous cell carcinomas are noticeably more common.

Numerous malignancies of the head and neck are curable, especially if detected early. Although eradicating cancer is the major objective of therapy, maintaining the function of the surrounding nerves, organs, and tissues is equally crucial. When planning therapy, physicians examine how treatment may influence a patient's quality of life, including how the patient feels, looks, speaks, eats, and breathes.

Surgical intervention, radiation treatment, chemotherapy, targeted therapy, and immunotherapy are the primary cancer treatments. Surgical procedures or radiation therapy alone, or a mix of the two, may be included in the treatment plan. The behavior of a specific head-neck cancer relies on its origin place (the primary site).

For instance, tumors that develop in the vocal cords behave quite differently from those that begin in the backside of the tongue, which is just an inch or less away from the vocal cords. Squamous cell carcinoma, which comes from the cells that cover the interior of the nose, mouth, and throat, is the most prevalent kind of cancer of the head and neck.

COVID-19 Impact Analysis

The COVID-19 pandemic has significantly impacted the care of different types of Head and neck cancer patients, having a greater impact on older patients, individuals operated primarily surgically, and those with fewer comorbidities. These individuals may experience poorer oncological outcomes due to missing or delayed diagnosis. Due to the COVID-19 pandemic, several cancer tests have been delayed or rescheduled, leaving a substantial number of people without access to required healthcare treatments. This interruption to cancer screening programs may have substantial consequences for patients, medical professionals, and health systems.

Market Growth Factors

Increasing Demand For Immunotherapy Treatment

Immunotherapy is an innovative treatment for cancer, including head and neck, lymphoma, melanoma, and non-small cell lung cancer. Some tumors respond well to conventional therapies such as chemotherapy. In other instances, immunotherapy is combined with conventional cancer therapies to increase the body's natural defenses against cancer. As part of its regular functionality, the immune system discovers and eliminates aberrant cells, so preventing or stifling the formation of several malignancies. Immune cells, for instance, are occasionally seen in and surrounding tumors.

Increasing Patient Population To Drive Market Growth

Head and neck cancers are classified according to their location. These regions include the oral cavity, pharynx, larynx, paranasal sinuses, and nasal cavity, as well as the salivary glands. An increase in alcohol and cigarette intake is a key cause of head and neck cancer. An estimated 75% of head and neck cancers are caused by alcohol and cigarette intake. Cancer will be the top cause of mortality, accounting for over 10 million fatalities, or one in six deaths.

Market Restraining Factors

Associated Side Effects Of Chemotherapy

Cancer of the head and neck are frequently treated with a mix of radiation and chemotherapy treatment. The adverse effects include hair loss, speech impairment, and loss of natural voice. In addition, after undergoing cancer surgery, people have difficulty eating. Although hair loss is a frequent side effect of chemotherapy, it does not affect everyone. Individuals can ask their care provider whether it is likely a medication side effect.

Therapy Type Outlook

Based on the Therapy Type, the Head and Neck Cancer Therapeutics Market is segmented into Chemotherapy, Immunotherapy, and Targeted Therapy. The immunotherapy segment acquired the highest revenue share in the head and neck therapeutics market in 2021. It is because immunotherapy make use of the immune system to treat cancer. Pembrolizumab, an anti-PD1 immunotherapy that targets cells with a deficiency in their capacity to repair DNA, may fall under this category.

Route of Administration Outlook

On the basis of the Route of Administration, the Head and Neck Cancer Therapeutics Market is divided into Injectable and Oral. The oral segment garnered a substantial revenue share in the head and neck cancer therapeutics market in 2021. Due to the rising number of oral medicinal medicines used to treat patients with Head and neck cancer. It is anticipated that the successful conclusion of the study and subsequent launch will stimulate segment growth. Patients with cancer are also administered oral chemotherapy.

Distribution Channel Outlook

By Distribution Channel, the Head and Neck Cancer Therapeutics Market is classified into Retail and Specialty Pharmacies, Hospital Pharmacies, and Online Pharmacies. The retail and specialty pharmacies witnessed the highest segment revenue share in the head and neck cancer therapeutics market in 2021. It is because specialty pharmacies offer medications unavailable in conventional pharmacies, such as immunotherapy drugs. Providing these drugs through a specialty pharmacy guarantees their appropriate and secure delivery.

Regional Outlook

Region-wise, the Head and Neck Cancer Therapeutics Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment registered the largest revenue share in the head and neck cancer therapeutics market in 2021. It is due to the government assistance for the expansion of the healthcare sector, attractive reimbursement rules, a high level of illness awareness, and easy access to high-quality healthcare facilities are among the factors that have contributed to the expansion of the regional market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eli Lilly and Company, Merck & Co., Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Teva Pharmaceuticals Industries Ltd., F. Hoffmann-La Roche Ltd., AstraZeneca Plc, Bristol Myers Squibb Company, and Clinigen Group PLC.

Strategies Deployed in Head And Neck Cancer Therapeutics Market

Aug-2022: Sanofi came into collaboration with Innovent Biologics, Inc., a biopharmaceutical company that develops, manufactures, and commercializes medicines for cancer treatment. Through this collaboration, the company aims to accelerate the development and future commercialization of oncology medicines as well as strengthen its presence in oncology in China.

Jul-2022: AstraZeneca completed the acquisition of TeneoTwo, comprising obtaining the rights to TNB-486, a BiTE currently in Phase I for R/R B-cell non-Hodgkin lymphoma. With this acquisition, the company broadened its hematology portfolio.

Feb-2022: Sanofi took over Amunix Pharmaceuticals, an immuno-oncology company. Through this acquisition, the company gets access to Amunix XPAC technology, Pro-XTEN, and XPAT which complement the company's existing R&D platform that further helps in accelerating and expanding innovative oncology medicines. Through this acquisition, Sanofi enhances its immuno-oncology portfolio by adding Amunix's promising pipeline.

Mar-2021: Takeda Pharmaceutical Company Limited came into an agreement to acquire Maverick Therapeutics, Inc., a private biopharmaceutical company developing conditionally active bispecific T-cell targeted immunotherapies. With this acquisition, the company would expand its Immuno-Oncology Portfolio with Maverick's Conditionally Active Bispecific T-cell Engagers COBRA Platform, which is designed to Target Solid Tumors.

Nov-2020: Merck (MSD) came into an agreement to acquire all outstanding shares of VelosBio, a portfolio company of Pappas Capital. Through this acquisition, Merck will strengthen its oncology pipeline with the addition of VLS-101, VelosBio's lead investigational candidate.

Sep-2020: Takeda Pharmaceutical opened a new R&D headquarters in Boston, Massachusetts. The new facility focuses on enhancing the development and end-to-end research capabilities of the company to develop cell therapies with the potential to expand into other therapeutic areas.

Aug-2020: Teva Pharmaceutical Industries joined hands with Alvotech, a combined biopharmaceutical company. Through this collaboration, Alvotech would allow Teva to access its technical expertise in working with the FDA to bring products to the U.S. market while enlarging its growing biosimilar offering and utilizing its unique cross-functional expertise throughout both generic and specialty medicines.

Oct-2018: AstraZeneca and MedImmune, the research and development division expanded its existing collaboration with Innate Pharma (Innate), a biotech company, that focuses on clinical-stage oncology. Through this collaboration, both companies are looking forward to innovate new medicines which accelerate their oncology portfolio.

Feb-2018: Bristol-Myers Squibb teamed up with Nektar Therapeutics, the global biopharmaceutical company. Through this collaboration, the companies would jointly create and market NKTR-214 in integration with Bristol-Myers Squibb's Opdivo and Opdivo plus Yervoy in more than 20 presentations across 9 tumor types, along with potential mixtures with other anti-cancer representatives from either of the individual businesses and/or third parties.

Scope of the Study

Market Segments covered in the Report:

By Therapy Type

  • Immunotherapy
  • Chemotherapy
  • Targeted Therapy

By Route of Administration

  • Injectable
  • Oral

By Distribution Channel

  • Retail & Specialty Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceuticals Industries Ltd.
  • F. Hoffmann-La Roche Ltd.
  • AstraZeneca Plc
  • Bristol Myers Squibb Company
  • Clinigen Group PLC

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Head & Neck Cancer Therapeutics Market, by Therapy Type
    • 1.4.2 Global Head & Neck Cancer Therapeutics Market, by Route of Administration
    • 1.4.3 Global Head & Neck Cancer Therapeutics Market, by Distribution Channel
    • 1.4.4 Global Head & Neck Cancer Therapeutics Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition and Scenarios
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Head And Neck Cancer Therapeutics Market

Chapter 4. Global Head & Neck Cancer Therapeutics Market by Therapy Type

  • 4.1 Global Immunotherapy Market by Region
  • 4.2 Global Chemotherapy Market by Region
  • 4.3 Global Targeted Therapy Market by Region

Chapter 5. Global Head & Neck Cancer Therapeutics Market by Route of Administration

  • 5.1 Global Injectable Market by Region
  • 5.2 Global Oral Market by Region

Chapter 6. Global Head & Neck Cancer Therapeutics Market by Distribution Channel

  • 6.1 Global Retail & Specialty Pharmacies Market by Region
  • 6.2 Global Hospital Pharmacies Market by Region
  • 6.3 Global Online Pharmacies Market by Region

Chapter 7. Global Head & Neck Cancer Therapeutics Market by Region

  • 7.1 North America Head & Neck Cancer Therapeutics Market
    • 7.1.1 North America Head & Neck Cancer Therapeutics Market by Therapy Type
      • 7.1.1.1 North America Immunotherapy Market by Country
      • 7.1.1.2 North America Chemotherapy Market by Country
      • 7.1.1.3 North America Targeted Therapy Market by Country
    • 7.1.2 North America Head & Neck Cancer Therapeutics Market by Route of Administration
      • 7.1.2.1 North America Injectable Market by Country
      • 7.1.2.2 North America Oral Market by Country
    • 7.1.3 North America Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.1.3.1 North America Retail & Specialty Pharmacies Market by Country
      • 7.1.3.2 North America Hospital Pharmacies Market by Country
      • 7.1.3.3 North America Online Pharmacies Market by Country
    • 7.1.4 North America Head & Neck Cancer Therapeutics Market by Country
      • 7.1.4.1 US Head & Neck Cancer Therapeutics Market
        • 7.1.4.1.1 US Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.1.4.1.2 US Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.1.4.1.3 US Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.1.4.2 Canada Head & Neck Cancer Therapeutics Market
        • 7.1.4.2.1 Canada Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.1.4.2.2 Canada Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.1.4.2.3 Canada Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.1.4.3 Mexico Head & Neck Cancer Therapeutics Market
        • 7.1.4.3.1 Mexico Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.1.4.3.2 Mexico Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.1.4.3.3 Mexico Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.1.4.4 Rest of North America Head & Neck Cancer Therapeutics Market
        • 7.1.4.4.1 Rest of North America Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.1.4.4.2 Rest of North America Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.1.4.4.3 Rest of North America Head & Neck Cancer Therapeutics Market by Distribution Channel
  • 7.2 Europe Head & Neck Cancer Therapeutics Market
    • 7.2.1 Europe Head & Neck Cancer Therapeutics Market by Therapy Type
      • 7.2.1.1 Europe Immunotherapy Market by Country
      • 7.2.1.2 Europe Chemotherapy Market by Country
      • 7.2.1.3 Europe Targeted Therapy Market by Country
    • 7.2.2 Europe Head & Neck Cancer Therapeutics Market by Route of Administration
      • 7.2.2.1 Europe Injectable Market by Country
      • 7.2.2.2 Europe Oral Market by Country
    • 7.2.3 Europe Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.2.3.1 Europe Retail & Specialty Pharmacies Market by Country
      • 7.2.3.2 Europe Hospital Pharmacies Market by Country
      • 7.2.3.3 Europe Online Pharmacies Market by Country
    • 7.2.4 Europe Head & Neck Cancer Therapeutics Market by Country
      • 7.2.4.1 Germany Head & Neck Cancer Therapeutics Market
        • 7.2.4.1.1 Germany Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.2.4.1.2 Germany Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.2.4.1.3 Germany Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.2.4.2 UK Head & Neck Cancer Therapeutics Market
        • 7.2.4.2.1 UK Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.2.4.2.2 UK Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.2.4.2.3 UK Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.2.4.3 France Head & Neck Cancer Therapeutics Market
        • 7.2.4.3.1 France Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.2.4.3.2 France Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.2.4.3.3 France Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.2.4.4 Russia Head & Neck Cancer Therapeutics Market
        • 7.2.4.4.1 Russia Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.2.4.4.2 Russia Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.2.4.4.3 Russia Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.2.4.5 Spain Head & Neck Cancer Therapeutics Market
        • 7.2.4.5.1 Spain Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.2.4.5.2 Spain Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.2.4.5.3 Spain Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.2.4.6 Italy Head & Neck Cancer Therapeutics Market
        • 7.2.4.6.1 Italy Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.2.4.6.2 Italy Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.2.4.6.3 Italy Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.2.4.7 Rest of Europe Head & Neck Cancer Therapeutics Market
        • 7.2.4.7.1 Rest of Europe Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.2.4.7.2 Rest of Europe Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.2.4.7.3 Rest of Europe Head & Neck Cancer Therapeutics Market by Distribution Channel
  • 7.3 Asia Pacific Head & Neck Cancer Therapeutics Market
    • 7.3.1 Asia Pacific Head & Neck Cancer Therapeutics Market by Therapy Type
      • 7.3.1.1 Asia Pacific Immunotherapy Market by Country
      • 7.3.1.2 Asia Pacific Chemotherapy Market by Country
      • 7.3.1.3 Asia Pacific Targeted Therapy Market by Country
    • 7.3.2 Asia Pacific Head & Neck Cancer Therapeutics Market by Route of Administration
      • 7.3.2.1 Asia Pacific Injectable Market by Country
      • 7.3.2.2 Asia Pacific Oral Market by Country
    • 7.3.3 Asia Pacific Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.3.3.1 Asia Pacific Retail & Specialty Pharmacies Market by Country
      • 7.3.3.2 Asia Pacific Hospital Pharmacies Market by Country
      • 7.3.3.3 Asia Pacific Online Pharmacies Market by Country
    • 7.3.4 Asia Pacific Head & Neck Cancer Therapeutics Market by Country
      • 7.3.4.1 China Head & Neck Cancer Therapeutics Market
        • 7.3.4.1.1 China Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.3.4.1.2 China Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.3.4.1.3 China Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.3.4.2 Japan Head & Neck Cancer Therapeutics Market
        • 7.3.4.2.1 Japan Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.3.4.2.2 Japan Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.3.4.2.3 Japan Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.3.4.3 India Head & Neck Cancer Therapeutics Market
        • 7.3.4.3.1 India Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.3.4.3.2 India Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.3.4.3.3 India Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.3.4.4 South Korea Head & Neck Cancer Therapeutics Market
        • 7.3.4.4.1 South Korea Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.3.4.4.2 South Korea Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.3.4.4.3 South Korea Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.3.4.5 Singapore Head & Neck Cancer Therapeutics Market
        • 7.3.4.5.1 Singapore Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.3.4.5.2 Singapore Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.3.4.5.3 Singapore Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.3.4.6 Malaysia Head & Neck Cancer Therapeutics Market
        • 7.3.4.6.1 Malaysia Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.3.4.6.2 Malaysia Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.3.4.6.3 Malaysia Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.3.4.7 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market
        • 7.3.4.7.1 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.3.4.7.2 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.3.4.7.3 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market by Distribution Channel
  • 7.4 LAMEA Head & Neck Cancer Therapeutics Market
    • 7.4.1 LAMEA Head & Neck Cancer Therapeutics Market by Therapy Type
      • 7.4.1.1 LAMEA Immunotherapy Market by Country
      • 7.4.1.2 LAMEA Chemotherapy Market by Country
      • 7.4.1.3 LAMEA Targeted Therapy Market by Country
    • 7.4.2 LAMEA Head & Neck Cancer Therapeutics Market by Route of Administration
      • 7.4.2.1 LAMEA Injectable Market by Country
      • 7.4.2.2 LAMEA Oral Market by Country
    • 7.4.3 LAMEA Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.4.3.1 LAMEA Retail & Specialty Pharmacies Market by Country
      • 7.4.3.2 LAMEA Hospital Pharmacies Market by Country
      • 7.4.3.3 LAMEA Online Pharmacies Market by Country
    • 7.4.4 LAMEA Head & Neck Cancer Therapeutics Market by Country
      • 7.4.4.1 Brazil Head & Neck Cancer Therapeutics Market
        • 7.4.4.1.1 Brazil Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.4.4.1.2 Brazil Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.4.4.1.3 Brazil Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.4.4.2 Argentina Head & Neck Cancer Therapeutics Market
        • 7.4.4.2.1 Argentina Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.4.4.2.2 Argentina Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.4.4.2.3 Argentina Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.4.4.3 UAE Head & Neck Cancer Therapeutics Market
        • 7.4.4.3.1 UAE Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.4.4.3.2 UAE Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.4.4.3.3 UAE Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.4.4.4 Saudi Arabia Head & Neck Cancer Therapeutics Market
        • 7.4.4.4.1 Saudi Arabia Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.4.4.4.2 Saudi Arabia Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.4.4.4.3 Saudi Arabia Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.4.4.5 South Africa Head & Neck Cancer Therapeutics Market
        • 7.4.4.5.1 South Africa Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.4.4.5.2 South Africa Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.4.4.5.3 South Africa Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.4.4.6 Nigeria Head & Neck Cancer Therapeutics Market
        • 7.4.4.6.1 Nigeria Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.4.4.6.2 Nigeria Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.4.4.6.3 Nigeria Head & Neck Cancer Therapeutics Market by Distribution Channel
      • 7.4.4.7 Rest of LAMEA Head & Neck Cancer Therapeutics Market
        • 7.4.4.7.1 Rest of LAMEA Head & Neck Cancer Therapeutics Market by Therapy Type
        • 7.4.4.7.2 Rest of LAMEA Head & Neck Cancer Therapeutics Market by Route of Administration
        • 7.4.4.7.3 Rest of LAMEA Head & Neck Cancer Therapeutics Market by Distribution Channel

Chapter 8. Company Profiles

  • 8.1 Eli Lilly And Company
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Regional Analysis
    • 8.1.4 Research & Development Expenses
  • 8.2 Merck & Co., Inc.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expenses
    • 8.2.5 Recent strategies and developments:
      • 8.2.5.1 Acquisition and Mergers:
  • 8.3 Sanofi S.A.
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expense
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Partnerships, Collaborations, and Agreements:
      • 8.3.5.2 Acquisition and Mergers:
  • 8.4 Takeda Pharmaceutical Company Limited
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Regional Analysis
    • 8.4.4 Research & Development Expense
    • 8.4.5 Recent strategies and developments:
      • 8.4.5.1 Acquisition and Mergers:
      • 8.4.5.2 Geographical Expansions:
  • 8.5 Teva Pharmaceutical Industries Ltd.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Regional Analysis
    • 8.5.4 Research & Development Expenses
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Partnerships, Collaborations, and Agreements:
  • 8.6 F. Hoffmann-La Roche Ltd.
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Segmental and Regional Analysis
    • 8.6.4 Research & Development Expense
  • 8.7 AstraZeneca PLC
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Regional Analysis
    • 8.7.4 Research & Development Expenses
    • 8.7.5 Recent strategies and developments:
      • 8.7.5.1 Partnerships, Collaborations, and Agreements:
      • 8.7.5.2 Acquisition and Mergers:
  • 8.8 Bristol Myers Squibb Company
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Regional Analysis
    • 8.8.4 Research & Development Expenses
    • 8.8.5 Recent strategies and developments:
      • 8.8.5.1 Partnerships, Collaborations, and Agreements:
  • 8.9 Clinigen Group PLC
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Segmental and Regional Analysis

LIST OF TABLES

  • TABLE 1 Global Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 2 Global Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 3 Global Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 4 Global Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 5 Global Immunotherapy Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Immunotherapy Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Chemotherapy Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Chemotherapy Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Targeted Therapy Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Targeted Therapy Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 12 Global Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 13 Global Injectable Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Injectable Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Oral Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Oral Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 18 Global Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 19 Global Retail & Specialty Pharmacies Market by Region, 2018 - 2021, USD Million
  • TABLE 20 Global Retail & Specialty Pharmacies Market by Region, 2022 - 2028, USD Million
  • TABLE 21 Global Hospital Pharmacies Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Hospital Pharmacies Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Online Pharmacies Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Online Pharmacies Market by Region, 2022 - 2028, USD Million
  • TABLE 25 Global Head & Neck Cancer Therapeutics Market by Region, 2018 - 2021, USD Million
  • TABLE 26 Global Head & Neck Cancer Therapeutics Market by Region, 2022 - 2028, USD Million
  • TABLE 27 North America Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 28 North America Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 29 North America Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 30 North America Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 31 North America Immunotherapy Market by Country, 2018 - 2021, USD Million
  • TABLE 32 North America Immunotherapy Market by Country, 2022 - 2028, USD Million
  • TABLE 33 North America Chemotherapy Market by Country, 2018 - 2021, USD Million
  • TABLE 34 North America Chemotherapy Market by Country, 2022 - 2028, USD Million
  • TABLE 35 North America Targeted Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 36 North America Targeted Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 37 North America Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 38 North America Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 39 North America Injectable Market by Country, 2018 - 2021, USD Million
  • TABLE 40 North America Injectable Market by Country, 2022 - 2028, USD Million
  • TABLE 41 North America Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 42 North America Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 43 North America Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 44 North America Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 45 North America Retail & Specialty Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 46 North America Retail & Specialty Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 47 North America Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 48 North America Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 49 North America Online Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 50 North America Online Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 51 North America Head & Neck Cancer Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 52 North America Head & Neck Cancer Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 53 US Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 54 US Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 55 US Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 56 US Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 57 US Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 58 US Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 59 US Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 60 US Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 61 Canada Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 62 Canada Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 63 Canada Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 64 Canada Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 65 Canada Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 66 Canada Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 67 Canada Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 68 Canada Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 69 Mexico Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 70 Mexico Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 71 Mexico Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 72 Mexico Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 73 Mexico Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 74 Mexico Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 75 Mexico Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 76 Mexico Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 77 Rest of North America Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 78 Rest of North America Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 79 Rest of North America Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 80 Rest of North America Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 81 Rest of North America Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 82 Rest of North America Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 83 Rest of North America Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 84 Rest of North America Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 85 Europe Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 86 Europe Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 87 Europe Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 88 Europe Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 89 Europe Immunotherapy Market by Country, 2018 - 2021, USD Million
  • TABLE 90 Europe Immunotherapy Market by Country, 2022 - 2028, USD Million
  • TABLE 91 Europe Chemotherapy Market by Country, 2018 - 2021, USD Million
  • TABLE 92 Europe Chemotherapy Market by Country, 2022 - 2028, USD Million
  • TABLE 93 Europe Targeted Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 94 Europe Targeted Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 95 Europe Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 96 Europe Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 97 Europe Injectable Market by Country, 2018 - 2021, USD Million
  • TABLE 98 Europe Injectable Market by Country, 2022 - 2028, USD Million
  • TABLE 99 Europe Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 100 Europe Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 101 Europe Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 102 Europe Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 103 Europe Retail & Specialty Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 104 Europe Retail & Specialty Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 105 Europe Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 106 Europe Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 107 Europe Online Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 108 Europe Online Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 109 Europe Head & Neck Cancer Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 110 Europe Head & Neck Cancer Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 111 Germany Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 112 Germany Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 113 Germany Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 114 Germany Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 115 Germany Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 116 Germany Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 117 Germany Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 118 Germany Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 119 UK Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 120 UK Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 121 UK Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 122 UK Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 123 UK Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 124 UK Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 125 UK Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 126 UK Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 127 France Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 128 France Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 129 France Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 130 France Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 131 France Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 132 France Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 133 France Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 134 France Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 135 Russia Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 136 Russia Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 137 Russia Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 138 Russia Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 139 Russia Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 140 Russia Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 141 Russia Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 142 Russia Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 143 Spain Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 144 Spain Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 145 Spain Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 146 Spain Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 147 Spain Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 148 Spain Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 149 Spain Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 150 Spain Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 151 Italy Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 152 Italy Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 153 Italy Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 154 Italy Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 155 Italy Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 156 Italy Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 157 Italy Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 158 Italy Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 159 Rest of Europe Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 160 Rest of Europe Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 161 Rest of Europe Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 162 Rest of Europe Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 163 Rest of Europe Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 164 Rest of Europe Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 165 Rest of Europe Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 166 Rest of Europe Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 167 Asia Pacific Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 168 Asia Pacific Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 169 Asia Pacific Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 170 Asia Pacific Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 171 Asia Pacific Immunotherapy Market by Country, 2018 - 2021, USD Million
  • TABLE 172 Asia Pacific Immunotherapy Market by Country, 2022 - 2028, USD Million
  • TABLE 173 Asia Pacific Chemotherapy Market by Country, 2018 - 2021, USD Million
  • TABLE 174 Asia Pacific Chemotherapy Market by Country, 2022 - 2028, USD Million
  • TABLE 175 Asia Pacific Targeted Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 176 Asia Pacific Targeted Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 177 Asia Pacific Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 178 Asia Pacific Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 179 Asia Pacific Injectable Market by Country, 2018 - 2021, USD Million
  • TABLE 180 Asia Pacific Injectable Market by Country, 2022 - 2028, USD Million
  • TABLE 181 Asia Pacific Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 182 Asia Pacific Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 183 Asia Pacific Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 184 Asia Pacific Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 185 Asia Pacific Retail & Specialty Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 186 Asia Pacific Retail & Specialty Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 187 Asia Pacific Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 188 Asia Pacific Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 189 Asia Pacific Online Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 190 Asia Pacific Online Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 191 Asia Pacific Head & Neck Cancer Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 192 Asia Pacific Head & Neck Cancer Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 193 China Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 194 China Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 195 China Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 196 China Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 197 China Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 198 China Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 199 China Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 200 China Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 201 Japan Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 202 Japan Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 203 Japan Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 204 Japan Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 205 Japan Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 206 Japan Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 207 Japan Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 208 Japan Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 209 India Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 210 India Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 211 India Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 212 India Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 213 India Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 214 India Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 215 India Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 216 India Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 217 South Korea Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 218 South Korea Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 219 South Korea Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 220 South Korea Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 221 South Korea Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 222 South Korea Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 223 South Korea Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 224 South Korea Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 225 Singapore Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 226 Singapore Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 227 Singapore Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 228 Singapore Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 229 Singapore Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 230 Singapore Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 231 Singapore Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 232 Singapore Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 233 Malaysia Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 234 Malaysia Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 235 Malaysia Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 236 Malaysia Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 237 Malaysia Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 238 Malaysia Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 239 Malaysia Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 240 Malaysia Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 241 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 242 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 243 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 244 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 245 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 246 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 247 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 248 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 249 LAMEA Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 250 LAMEA Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 251 LAMEA Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 252 LAMEA Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 253 LAMEA Immunotherapy Market by Country, 2018 - 2021, USD Million
  • TABLE 254 LAMEA Immunotherapy Market by Country, 2022 - 2028, USD Million
  • TABLE 255 LAMEA Chemotherapy Market by Country, 2018 - 2021, USD Million
  • TABLE 256 LAMEA Chemotherapy Market by Country, 2022 - 2028, USD Million
  • TABLE 257 LAMEA Targeted Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 258 LAMEA Targeted Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 259 LAMEA Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 260 LAMEA Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 261 LAMEA Injectable Market by Country, 2018 - 2021, USD Million
  • TABLE 262 LAMEA Injectable Market by Country, 2022 - 2028, USD Million
  • TABLE 263 LAMEA Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 264 LAMEA Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 265 LAMEA Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 266 LAMEA Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 267 LAMEA Retail & Specialty Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 268 LAMEA Retail & Specialty Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 269 LAMEA Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 270 LAMEA Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 271 LAMEA Online Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 272 LAMEA Online Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 273 LAMEA Head & Neck Cancer Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 274 LAMEA Head & Neck Cancer Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 275 Brazil Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 276 Brazil Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 277 Brazil Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 278 Brazil Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 279 Brazil Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 280 Brazil Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 281 Brazil Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 282 Brazil Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 283 Argentina Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 284 Argentina Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 285 Argentina Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 286 Argentina Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 287 Argentina Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 288 Argentina Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 289 Argentina Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 290 Argentina Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 291 UAE Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 292 UAE Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 293 UAE Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 294 UAE Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 295 UAE Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 296 UAE Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 297 UAE Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 298 UAE Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 299 Saudi Arabia Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 300 Saudi Arabia Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 301 Saudi Arabia Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 302 Saudi Arabia Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 303 Saudi Arabia Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 304 Saudi Arabia Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 305 Saudi Arabia Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 306 Saudi Arabia Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 307 South Africa Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 308 South Africa Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 309 South Africa Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 310 South Africa Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 311 South Africa Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 312 South Africa Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 313 South Africa Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 314 South Africa Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 315 Nigeria Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 316 Nigeria Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 317 Nigeria Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 318 Nigeria Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 319 Nigeria Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 320 Nigeria Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 321 Nigeria Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 322 Nigeria Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 323 Rest of LAMEA Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 324 Rest of LAMEA Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 325 Rest of LAMEA Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 326 Rest of LAMEA Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 327 Rest of LAMEA Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 328 Rest of LAMEA Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 329 Rest of LAMEA Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 330 Rest of LAMEA Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 331 Key Information - Eli Lilly And Company
  • TABLE 332 KEY INFORMATION - MERCK & CO., INC.
  • TABLE 333 Key Information - Sanofi S.A.
  • TABLE 334 Key Information - Takeda Pharmaceutical Company Limited
  • TABLE 335 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 336 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
  • TABLE 337 KEY INFORMATION - AstraZeneca PLC
  • TABLE 338 Key Information - Bristol Myers Squibb Company
  • TABLE 339 Key Information - Clinigen Group PLC

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Head & Neck Cancer Therapeutics Market share by Therapy Type, 2021
  • FIG 3 Global Head & Neck Cancer Therapeutics Market share by Therapy Type, 2028
  • FIG 4 Global Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2028, USD Million
  • FIG 5 Global Head & Neck Cancer Therapeutics Market share by Route of Administration, 2021
  • FIG 6 Global Head & Neck Cancer Therapeutics Market share by Route of Administration, 2028
  • FIG 7 Global Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2028, USD Million
  • FIG 8 Global Head & Neck Cancer Therapeutics Market share by Distribution Channel, 2021
  • FIG 9 Global Head & Neck Cancer Therapeutics Market share by Distribution Channel, 2028
  • FIG 10 Global Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2028, USD Million
  • FIG 11 Global Head & Neck Cancer Therapeutics Market share by Region, 2021
  • FIG 12 Global Head & Neck Cancer Therapeutics Market share by Region, 2028
  • FIG 13 Global Head & Neck Cancer Therapeutics Market by Region, 2018 - 2028, USD Million